1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Generic Oncology Drug Market
5.1 Market Performance
5.2 Market Breakup by Cancer Type
5.3 Market Breakup by Drug Type
5.4 Market Breakup by Distribution Channel
5.5 Market Breakup by Region
5.6 Market Forecast
6 North America Generic Oncology Drug Market
6.1 Market Performance
6.2 Impact of COVID-19
6.3 Market Forecast
7 North America Generic Oncology Drug Market: Breakup by Cancer Type
7.1 Lungs and Bronchus Cancer
7.2 Colon and Rectal Cancer
7.3 Breast Cancer
7.4 Prostate Cancer
7.5 Others
8 North America Generic Oncology Drug Market: Breakup by Drug Type
8.1 Oral Drugs
8.2 Injectables
8.3 Others
9 North America Generic Oncology Drug Market: Breakup by Distribution Channel
9.1 Retail Pharmacies
9.2 Hospital Pharmacies
10 North America Generic Oncology Drug Market: Breakup by Country
10.1 United States
10.1.1 Historical Market Trends
10.1.2 Market Breakup by Cancer Type
10.1.3 Market Breakup by Drug Type
10.1.4 Market Breakup by Distribution Channel
10.1.5 Market Forecast
10.2 Canada
10.2.1 Historical Market Trends
10.2.2 Market Breakup by Cancer Type
10.2.3 Market Breakup by Drug Type
10.2.4 Market Breakup by Distribution Channel
10.2.5 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porter’s Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Rivalry
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
List of Figures
Figure 1: North America: Generic Oncology Drug Market: Major Drivers and Challenges
Figure 2: Global: Generic Oncology Drug Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Generic Oncology Drug Market: Breakup by Cancer Type (in %), 2023
Figure 4: Global: Generic Oncology Drug Market: Breakup by Drug Type (in %), 2023
Figure 5: Global: Generic Oncology Drug Market: Breakup by Distribution Channel (in %), 2023
Figure 6: Global: Generic Oncology Drug Market: Breakup by Region (in %), 2023
Figure 7: Global: Generic Oncology Drug Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 8: North America: Generic Oncology Drug Market: Sales Value (in Billion US$), 2018-2023
Figure 9: North America: Generic Oncology Drug Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 10: North America: Generic Oncology Drug Market: Breakup by Cancer Type (in %), 2023
Figure 11: North America: Generic Oncology Drug (Lungs and Bronchus Cancer) Market: Sales Value (in Billion US$), 2018 & 2023
Figure 12: North America: Generic Oncology Drug (Lungs and Bronchus Cancer) Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 13: North America: Generic Oncology Drug (Colon and Rectal Cancer) Market: Sales Value (in Billion US$), 2018 & 2023
Figure 14: North America: Generic Oncology Drug (Colon and Rectal Cancer) Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 15: North America: Generic Oncology Drug (Breast Cancer) Market: Sales Value (in Billion US$), 2018 & 2023
Figure 16: North America: Generic Oncology Drug (Breast Cancer) Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 17: North America: Generic Oncology Drug (Prostate Cancer) Market: Sales Value (in Billion US$), 2018 & 2023
Figure 18: North America: Generic Oncology Drug (Prostate Cancer) Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 19: North America: Generic Oncology Drug (Other Cancer Types) Market: Sales Value (in Billion US$), 2018 & 2023
Figure 20: North America: Generic Oncology Drug (Other Cancer Types) Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 21: North America: Generic Oncology Drug Market: Breakup by Drug Type (in %), 2023
Figure 22: North America: Generic Oncology Drug (Oral Drugs) Market: Sales Value (in Billion US$), 2018 & 2023
Figure 23: North America: Generic Oncology Drug (Oral Drugs) Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 24: North America: Generic Oncology Drug (Injectables) Market: Sales Value (in Billion US$), 2018 & 2023
Figure 25: North America: Generic Oncology Drug (Injectables) Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 26: North America: Generic Oncology Drug (Other Drug Types) Market: Sales Value (in Billion US$), 2018 & 2023
Figure 27: North America: Generic Oncology Drug (Other Drug Types) Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 28: North America: Generic Oncology Drug Market: Breakup by Distribution Channel (in %), 2023
Figure 29: North America: Generic Oncology Drug Market: Sales through Retail Pharmacies (in Billion US$), 2018 & 2023
Figure 30: North America: Generic Oncology Drug Market Forecast: Sales through Retail Pharmacies (in Billion US$), 2024-2032
Figure 31: North America: Generic Oncology Drug Market: Sales through Hospital Pharmacies (in Billion US$), 2018 & 2023
Figure 32: North America: Generic Oncology Drug Market Forecast: Sales through Hospital Pharmacies (in Billion US$), 2024-2032
Figure 33: North America: Generic Oncology Drug Market: Breakup by Country (in %), 2023
Figure 34: United States: Generic Oncology Drug Market: Sales Value (in Billion US$), 2018-2023
Figure 35: United States: Generic Oncology Drug Market: Breakup by Cancer Type (in %), 2023
Figure 36: United States: Generic Oncology Drug Market: Breakup by Drug Type (in %), 2023
Figure 37: United States: Generic Oncology Drug Market: Breakup by Distribution Channel (in %), 2023
Figure 38: United States: Generic Oncology Drug Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 39: Canada: Generic Oncology Drug Market: Sales Value (in Billion US$), 2018-2023
Figure 40: Canada: Generic Oncology Drug Market: Breakup by Cancer Type (in %), 2023
Figure 41: Canada: Generic Oncology Drug Market: Breakup by Drug Type (in %), 2023
Figure 42: Canada: Generic Oncology Drug Market: Breakup by Distribution Channel (in %), 2023
Figure 43: Canada: Generic Oncology Drug Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 44: North America: Generic Oncology Drug Industry: SWOT Analysis
Figure 45: North America: Generic Oncology Drug Industry: Value Chain Analysis
Figure 46: North America: Generic Oncology Drug Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: North America: Generic Oncology Drug Market: Key Industry Highlights, 2023 and 2032
Table 2: North America: Generic Oncology Drug Market Forecast: Breakup by Cancer Type (in Billion US$), 2024-2032
Table 3: North America: Generic Oncology Drug Market Forecast: Breakup by Drug Type (in Billion US$), 2024-2032
Table 4: North America: Generic Oncology Drug Market Forecast: Breakup by Distribution Channel (in Billion US$), 2024-2032
Table 5: North America: Generic Oncology Drug Market Forecast: Breakup by Country (in Billion US$), 2024-2032
Table 6: North America: Generic Oncology Drug Market: Competitive Structure
Table 7: North America: Generic Oncology Drug Market: Key Players